Intracranial Primary Malignant Solitary Fibrous Tumor/Hemangiopericytoma Masquerading as Meningioma: Report of a Rare Case
- PMID: 33149660
- PMCID: PMC7605615
- DOI: 10.2147/IJGM.S279483
Intracranial Primary Malignant Solitary Fibrous Tumor/Hemangiopericytoma Masquerading as Meningioma: Report of a Rare Case
Abstract
Background: Intracranial solitary fibrous tumors/hemangiopericytomas (SFTs/HPCs) are rare spindle cell tumors originating from interstitial tissue that are usually benign. Primary malignant intracranial SFTs/HPCs are extremely rare. Here we describe a case of malignant intracranial SFT/HPC.
Case presentation: A 59-year-old woman presented with a space-occupying lesion in the left cerebellar tentorium. Based on imaging findings, we made a preoperative diagnosis of meningioma. During the operation, we found that the tumor had an abnormally rich blood supply and could not be completely removed. Histologic findings, immunophenotype (positive for cluster of differentiation [CD]34, CD99, signal transducer and activator of transcription 6, and B cell lymphoma 2), and a Ki-67 proliferative index of 20-30% for the primary tumor were typical of malignant intracranial SFT/HPC. The tumors showed high sensitivity to radiotherapy and the residual tumor was significantly reduced after intensity-modulated radiation therapy. The patient has had no neurologic symptoms and no recurrence of the tumor in 2 years of follow-up.
Conclusion: Intracranial SFTs/HPCs are extremely rare. Radiologic examination before the operation is helpful for making a definite diagnosis and judging tumor grade; STAT6 immunohistochemistry is a sensitive alternative diagnostic method. Adjuvant radiotherapy is effective in cases of incomplete resection, and strict follow-up is essential in order to monitor for possible recurrence.
Keywords: intracranial; malignant; radiation therapy; solitary fibrous tumor.
© 2020 Sun et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures



Similar articles
-
Delayed pulmonary metastasis and recurrence of intracranial malignant solitary fibrous tumor/hemangiopericytoma: Case report and literature review.Oncol Lett. 2022 Jun 14;24(2):255. doi: 10.3892/ol.2022.13375. eCollection 2022 Aug. Oncol Lett. 2022. PMID: 35765276 Free PMC article.
-
A review of solitary fibrous tumor/hemangiopericytoma tumor and a comparison of risk factors for recurrence, metastases, and death among patients with spinal and intracranial tumors.Neurosurg Rev. 2021 Jun;44(3):1299-1312. doi: 10.1007/s10143-020-01335-x. Epub 2020 Jun 18. Neurosurg Rev. 2021. PMID: 32556679
-
Meningeal solitary fibrous tumor/hemangiopericytoma: Emphasizing on STAT 6 immunohistochemistry with a review of literature.Neurol India. 2018 Sep-Oct;66(5):1419-1426. doi: 10.4103/0028-3886.241365. Neurol India. 2018. PMID: 30233017 Review.
-
Surveillance for metastatic hemangiopericytoma-solitary fibrous tumors-systematic literature review on incidence, predictors and diagnosis of extra-cranial disease.J Neurooncol. 2018 Jul;138(3):447-467. doi: 10.1007/s11060-018-2836-2. Epub 2018 Mar 17. J Neurooncol. 2018. PMID: 29551003
-
Intracranial anaplastic solitary fibrous tumor/hemangiopericytoma: immunohistochemical markers for definitive diagnosis.Neurosurg Rev. 2021 Jun;44(3):1591-1600. doi: 10.1007/s10143-020-01348-6. Epub 2020 Jul 15. Neurosurg Rev. 2021. PMID: 32671693 Review.
Cited by
-
The role of tumor parenchyma and brain cortex signal intensity ratio in differentiating solitary fibrous tumors and meningiomas.Discov Oncol. 2024 Feb 8;15(1):32. doi: 10.1007/s12672-024-00883-8. Discov Oncol. 2024. PMID: 38329652 Free PMC article.
-
[Research progress of intraspinal solitary fibrous tumor].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2023 Feb 15;37(2):228-232. doi: 10.7507/1002-1892.202209084. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2023. PMID: 36796821 Free PMC article. Review. Chinese.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous